Director Bonuses And The Entire Fairness Test

Law360, New York (December 12, 2007, 12:00 AM EST) -- A recent Delaware case, Valeant Pharmaceuticals International v. Jerney, is an important reminder of the care which should be taken by directors in considering bonuses that include payments to themselves.

Delaware courts in particular are focusing heavily on issues of director independence and Jerney is the latest example of the bright light which the courts will bring to bear on directors’ self-interest.

Valeant, a biotech company, adopted a stock option bonus program (which included directors) at a time when the company’s fortunes were flying high and...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.